Application & Review Process
Most grants provided by Cure Alzheimer’s Fund originate as referrals from already funded investigators or as solicitations by CureAlz. However, we welcome letters of inquiry from any qualified scientist. We will not consider unsolicited proposals. Letters of inquiry and proposals are accepted and reviewed on a rolling basis; there is no set timeline for applications, funding decisions, or funding initiation.
Letters of inquiry should be no more than one to two pages in length and should include: the hypothesis to be pursued; the rationale for doing so; a high-level description of how the scientific aims would be pursued; and sufficient information to demonstrate the scientist’s ability to do so. CureAlz will respond to all letters of inquiry.
CureAlz will request full proposals from scientists whose letters of inquiry align with CureAlz’s mission, scientific standards, and funding priorities. We will send specific information about proposal parameters and requirements with our proposal request. Out of respect for applicants’ time, our goal is to request proposals only where there is a high likelihood of funding. As a matter of policy, CureAlz does not provide its reasons for declining to request or fund a proposal.
Investigators using animal models must provide proof that their animal plans meet their institution’s standard of care. Investigators working with human subjects must provide proof that their research plan has Institutional Review Board approval. All projects must use and report on both male and female animals and/or humans and/or biological samples absent compelling scientific justification for the use of only one sex; time and expense are not sufficient justifications.
CureAlz provides funding to not-for-profit institutions around the world. Although CureAlz will consider applications from for-profit entities, research that will benefit the entire field is preferred over development of proprietary molecules or therapeutics. Support to for-profit entities will only be offered on an investment basis and will require demonstrated financial viability.